Therapeutic potential of folic acid supplementation for cardiovascular disease prevention through homocysteine lowering and blockade in rheumatoid arthritis patients

Biomarker Research
Mickael Essouma, Jean Jacques N Noubiap

Abstract

Rheumatoid arthritis (RA) is a chronic inflammatory disease that preferentially affects joints, and characterized by an approximately two-fold increased risk of cardiovascular diseases compared with the general population. Beyond classical cardiovascular risk factors, systemic inflammatory markers are primarily involved. Hence, anti-inflammatory strategies such as homocysteine-lowering interventions are warranted. Indeed, hyperhomocysteinemia is commonly found in RA patients as a result of both genetic and non-genetic factors including older age, male gender, disease-specific features and disease-modifying antirheumatic drugs. Most importantly in the pathophysiology of hyperhomocysteinemia and its related cardiovascular diseases in RA, there is a bi-directional link between immuno-inflammatory activation and hyperhomocysteinemia. As such, chronic immune activation causes B vitamins (including folic acid) depletion and subsequent hyperhomocysteinemia. In turn, hyperhomocysteinemia may perpetrate immuno-inflammatory stimulation via nuclear factor ƙappa B enhancement. This chronic immune activation is a key determinant of hyperhomocysteinemia-related cardiovascular diseases in RA patients. Folate, a homocysteine-lowering therapy c...Continue Reading

References

Jan 1, 1982·Annual Review of Nutrition·B Seetharam, D H Alpers
Mar 21, 2002·The Journal of Pharmacy and Pharmacology·Sahar E el-SwefyHoda E Mohamed
Nov 26, 2003·Clinica Chimica Acta; International Journal of Clinical Chemistry·Katharina SchroecksnadelDietmar Fuchs
Sep 14, 2004·Annals of the Rheumatic Diseases·R NissinenO Vaarala
Aug 9, 2005·Seminars in Arthritis and Rheumatism·Miguel A Gonzalez-GayJavier Martin
Mar 30, 2006·Current Rheumatology Reports·Ewa Olech, Joan T Merrill
Apr 28, 2006·Scandinavian Journal of Rheumatology·M A Lopez-OlivoJ I Gamez-Nava
Jul 24, 2007·Autoimmunity Reviews·Pietro Enea LazzeriniFranco Laghi Pasini
Sep 8, 2007·The American Journal of Clinical Nutrition·Angelika de BreeRichard Draijer
Mar 4, 2008·Journal of the American Dietetic Association·Kathleen Woolf, Melinda M Manore
May 7, 2008·Joint, Bone, Spine : Revue Du Rhumatisme·Imane El BouchtiJean Sibilia
Dec 9, 2008·Metabolism: Clinical and Experimental·Futoshi AnanHironobu Yoshimatsu
Mar 14, 2009·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·Chihiro FujimakiKunihiko Itoh
Jun 2, 2009·Cardiovascular Toxicology·Jacob JosephJoseph Loscalzo
Jun 30, 2009·European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery·N KhandanpourM P Armon
Feb 13, 2010·Arteriosclerosis, Thrombosis, and Vascular Biology·Pascal N TyrrellTimothy J Bradley
Jun 1, 2010·Rheumatic Diseases Clinics of North America·Mariana J Kaplan
Nov 12, 2010·Journal of Inherited Metabolic Disease·Robert ClarkeSarah Lewington
Aug 23, 2011·The American Journal of Cardiology·Renata MichaDariush Mozaffarian
Mar 20, 2012·Annals of the Rheumatic Diseases·Juan Antonio Avina-ZubietaDiane Lacaille
Mar 1, 2010·Journal of Dietary Supplements·Camille Feitoza França, Lucia Marques Vianna
Apr 10, 2012·Atherosclerosis·Monica S RochaHenk J Blom
Apr 25, 2012·Mediators of Inflammation·Elisabetta ProfumoRachele Riganò
May 23, 2012·International Journal of Clinical Practice·Y HuoX Wang
Nov 30, 2012·Arthritis·Juan Camilo Sarmiento-MonroyAdriana Rojas-Villarraga
Jan 24, 2013·PloS One·Monique AlbersenNanda M Verhoeven-Duif
Feb 5, 2013·Current Rheumatology Reports·Nigel YeohSimon Stebbings

❮ Previous
Next ❯

Citations

Mar 17, 2016·Autoimmunity Reviews·Zoltán SzekaneczYehuda Shoenfeld
Mar 27, 2018·Mediators of Inflammation·Manuela Di FrancoFrancesca Romana Spinelli
Aug 23, 2017·Expert Opinion on Therapeutic Targets·Heng LiJianping Zuo
Jun 15, 2017·Frontiers in Aging Neuroscience·Rita MorettiClaudio Tiribelli
Dec 20, 2017·Current Opinion in Rheumatology·György NagyEdit I Buzás
Jan 11, 2019·International Journal of Molecular Sciences·Rita Moretti, Paola Caruso
Aug 31, 2017·Journal of the American College of Nutrition·Huizi TianWeidong Zhang
Jul 23, 2016·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Olga GolubnitschajaGodfrey Grech
May 4, 2017·International Journal of Food Sciences and Nutrition·Ewa SicińskaPaul M Finglas
Dec 11, 2020·Differentiation; Research in Biological Diversity·R S SeelanM M Pisano
Mar 7, 2021·International Journal of Molecular Sciences·Rita MorettiClaudio Tiribelli
Jun 13, 2021·Neuroscience and Biobehavioral Reviews·Gerwyn MorrisBasant K Puri
Aug 28, 2020·Advances in Therapy·Alan D KayeChristopher G Kevil

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Related Papers

Foot and Ankle Clinics
Marlyn Lorenzo
Giornale italiano di cardiologia : organo ufficiale della Federazione italiana di cardiologia : organo ufficiale della Società italiana di chirurgia cardiaca
Maria Grazia BendiniGiampiero Giordano
The Journal of Dermatological Treatment
Paolo GisondiGiampiero Girolomoni
The New England Journal of Medicine
Kaare Harald BønaaNORVIT Trial Investigators
© 2021 Meta ULC. All rights reserved